Skip to main content

For informational and research purposes only.

Medical DisclaimerTerms of Use

Amino Acid

L-Serine: The Complete Supplement Guide

By Doserly Editorial Team
On this page

Quick Reference Card

Attribute

Common Name

Detail
L-Serine

Attribute

Other Names / Aliases

Detail
Serine, (S)-2-Amino-3-hydroxypropanoic acid, beta-Hydroxyalanine, Ser, S

Attribute

Category

Detail
Conditionally Essential Amino Acid (nonessential under normal conditions)

Attribute

Primary Forms & Variants

Detail
L-Serine (free-form powder or capsule, the protein-building isomer); Phosphatidylserine (a downstream phospholipid metabolite with its own evidence base, not interchangeable)

Attribute

Typical Dose Range

Detail
500-3,000 mg/day for general wellness; clinical protocols may use 5-30 g/day under medical supervision

Attribute

RDA / AI / UL

Detail
No formal RDA, AI, or UL established. Endogenous synthesis from 3-phosphoglycerate meets needs in healthy individuals. Typical dietary intake is approximately 3.5-8 g/day.

Attribute

Common Delivery Forms

Detail
Powder, capsules

Attribute

Best Taken With / Without Food

Detail
Can be taken with or without food. Dividing higher doses across meals improves GI tolerance.

Attribute

Key Cofactors

Detail
Folate, Vitamin B12, Vitamin B6 (support one-carbon metabolism); Zinc, Choline (support methylation and membrane pathways)

Attribute

Storage Notes

Detail
Store at room temperature in a dry place away from direct sunlight. Powder should be kept in a tightly sealed container to prevent moisture absorption.

Overview

The Basics

L-Serine is one of the twenty amino acids your body uses to build proteins, but its importance extends far beyond that basic construction role. Think of it as a metabolic crossroads: it sits at the intersection of protein synthesis, brain cell maintenance, and the biochemical pathways that copy your DNA.

Your body can make L-serine on its own from glucose, so under normal circumstances it is classified as "nonessential." But that label is misleading. During periods of growth, injury repair, neurological stress, or intensive training, demand for L-serine can outpace your body's production capacity. In these situations, dietary intake and supplementation become more relevant. A typical diet provides roughly 3.5 to 8 grams of L-serine per day from protein-rich foods like eggs, meat, fish, dairy, soy, and legumes [1][2].

People supplement with L-serine for several reasons. The strongest clinical evidence comes from rare neurological conditions: hereditary sensory and autonomic neuropathy type 1 (HSAN1), where high-dose L-serine can reduce toxic compounds that damage nerves, and GRIN-related disorders in children, where it has shown improvements in motor function and quality of life [3][4][5]. There is also early-stage research in ALS (Lou Gehrig's disease), where Phase I trials have shown that L-serine is safe at high doses and may slow disease progression, though large confirmatory trials are still needed [6][7].

In the wellness space, L-serine draws interest for cognitive support, sleep improvement, and general neuroprotection. These applications are mechanistically plausible, since L-serine feeds the production of phosphatidylserine (a key brain cell membrane component) and fuels the one-carbon metabolism cycle that supports DNA synthesis and methylation. However, direct clinical evidence for these everyday uses remains limited [1][8].

An important distinction: L-serine is not the same as D-serine, despite sharing the same base molecule. D-serine acts directly on NMDA receptors in the brain and has a different safety profile. Phosphatidylserine, another related compound, is a downstream product of L-serine metabolism and has its own separate evidence base. These three compounds are not interchangeable [1][9].

The Science

L-Serine (2-amino-3-hydroxypropanoic acid, C3H7NO3, molecular weight 105.09 g/mol) is a proteinogenic amino acid classified as conditionally essential. It is synthesized endogenously from 3-phosphoglycerate, an intermediate of glycolysis, via the phosphorylated pathway involving three enzymes: 3-phosphoglycerate dehydrogenase (3-PGDH/PHGDH), phosphoserine aminotransferase (PSAT1), and phosphoserine phosphatase (PSP). This pathway is particularly active in astrocytes and neurons of the central nervous system [1][8].

L-Serine occupies a hub position in intermediary metabolism:

  • One-carbon metabolism: Serine hydroxymethyltransferase (SHMT) catalyzes the reversible conversion of L-serine to glycine, donating a one-carbon unit to tetrahydrofolate (THF) to form 5,10-methylenetetrahydrofolate. This reaction is the primary source of one-carbon units for nucleotide synthesis (purines and thymidylate) and supports SAM-dependent methylation reactions [1][8].
  • Sphingolipid synthesis: L-Serine is a substrate for serine palmitoyltransferase (SPT), the rate-limiting enzyme in de novo sphingolipid biosynthesis. SPT condenses L-serine with palmitoyl-CoA to form 3-ketosphinganine, which is subsequently converted to ceramides, sphingomyelin, and other sphingolipids critical for neuronal membrane integrity and myelin sheath formation [3][8].
  • Phospholipid synthesis: L-Serine is incorporated into phosphatidylserine via phosphatidylserine synthase enzymes, contributing to cell membrane structure and signaling [1].
  • D-Serine production: Serine racemase converts L-serine to D-serine, a co-agonist at synaptic NMDA receptors involved in neurotransmission, synaptic plasticity, and learning [9].
  • Glycine receptor agonism: L-Serine itself acts as an agonist at glycine receptors, contributing to inhibitory neurotransmission [8][10].
  • PPAR-gamma upregulation: L-Serine upregulates peroxisome proliferator-activated receptor gamma (PPAR-gamma) expression, which plays a role in microglial polarization from pro-inflammatory M1 to anti-inflammatory M2 phenotypes, contributing to neuroprotective and anti-inflammatory effects [8][10].

Chemical & Nutritional Identity

Property

Chemical Name

Value
(S)-2-Amino-3-hydroxypropanoic acid

Property

Molecular Formula

Value
C3H7NO3

Property

Molecular Weight

Value
105.09 g/mol

Property

CAS Number

Value
56-45-1

Property

PubChem CID

Value
5951

Property

Category

Value
Conditionally essential amino acid

Property

RDA / AI / UL

Value
Not established. Typical dietary intake 3.5-8 g/day.

L-Serine exists as the L-enantiomer, which is the biologically active form used in protein synthesis. Its mirror image, D-serine, has distinct biological activity as an NMDA receptor co-agonist and is synthesized from L-serine by the enzyme serine racemase. The two enantiomers are not interchangeable for supplementation purposes and have different safety profiles [1][9].

Common supplement forms include:

  • L-Serine (free-form): The most common supplement form. Available as powder or capsules. Used in both wellness supplementation (500-3,000 mg/day) and clinical research protocols (up to 30 g/day under supervision).
  • Phosphatidylserine: Not a form of L-serine supplementation but a downstream metabolite. Phosphatidylserine is a phospholipid with its own extensive evidence base for cognitive function. It has different dosing, mechanisms, and clinical applications.

Mechanism of Action

The Basics

L-Serine works in your body through several interconnected pathways, each contributing to different health outcomes.

First, it serves as building material for your brain's protective infrastructure. Neurons need specialized fats called sphingolipids and phospholipids to maintain their cell membranes and myelin sheaths (the insulating coating around nerve fibers that allows signals to travel quickly). L-serine provides the raw material for making these fats. When L-serine is scarce, the enzyme responsible for sphingolipid production (serine palmitoyltransferase) can mistakenly use alanine instead, producing toxic compounds called deoxysphingolipids that damage nerves. This is exactly what happens in HSAN1, and it explains why flooding the system with L-serine can redirect the enzyme back to its proper substrate [3][8].

Second, L-serine feeds what biochemists call one-carbon metabolism. This is a set of chemical reactions that your body uses to make new DNA and RNA (critical for dividing cells) and to perform methylation (a chemical process that regulates gene expression). Any tissue with rapid cell turnover, including immune cells, healing wounds, and training-adapted muscle, has higher demand for these one-carbon units [1][8].

Third, L-serine is the precursor for D-serine, a signaling molecule in the brain that helps activate NMDA receptors. These receptors are essential for learning, memory, and synaptic plasticity. By providing the raw material for D-serine production, L-serine indirectly supports cognitive function [9].

Finally, L-serine acts directly on glycine receptors (inhibitory receptors in the nervous system) and increases the expression of PPAR-gamma, a protein that shifts immune cells in the brain from an inflammatory to a protective state. This dual action contributes to its observed neuroprotective and anti-inflammatory effects in animal and cell studies [8][10].

The Science

Sphingolipid biosynthesis pathway: Serine palmitoyltransferase (SPT), a heterodimeric enzyme composed of SPTLC1 and SPTLC2 subunits, catalyzes the condensation of L-serine with palmitoyl-CoA to produce 3-ketosphinganine. This is the committed step in de novo sphingolipid synthesis. When L-serine availability is reduced or when SPTLC1 mutations alter enzyme substrate specificity (as in HSAN1), SPT utilizes L-alanine, generating 1-deoxy-3-ketosphinganine and subsequently 1-deoxysphingolipids (1-deoxySLs). These atypical metabolites lack the C1-hydroxyl group required for conversion to complex sphingolipids or degradation, leading to accumulation and neurotoxicity [3][11].

One-carbon metabolism: The SHMT-catalyzed conversion of L-serine to glycine transfers a hydroxymethyl group to THF, generating 5,10-CH2-THF. This intermediate feeds thymidylate synthase (for dTMP production), MTHFR (for 5-methyl-THF and homocysteine remethylation to methionine), and the purine synthesis pathway. Dietary serine and cystine have been shown in human RCTs to attenuate the homocysteine-raising effect of dietary methionine, highlighting serine's role in methylation homeostasis [1][12].

Neurotransmitter modulation: L-Serine serves as the sole precursor for D-serine via serine racemase, predominantly expressed in astrocytes and some neurons. D-Serine is the primary co-agonist at the glycine binding site of synaptic NMDA receptors (NR1/NR2 subtypes), with higher potency than glycine at synaptic receptors. L-Serine itself activates strychnine-sensitive glycine receptors, contributing to inhibitory neurotransmission and neuronal excitability modulation [8][9][10].

Anti-inflammatory signaling: L-Serine upregulates PPAR-gamma expression in microglia, promoting M2 polarization (anti-inflammatory, reparative phenotype) and suppressing M1-mediated neuroinflammation. This mechanism has been demonstrated in traumatic brain injury and stroke models, where L-serine treatment reduced pro-inflammatory cytokine release and promoted neuronal survival [8][10].

Absorption & Bioavailability

The Basics

L-Serine is a small, water-soluble amino acid that is generally well absorbed from the digestive tract. When consumed in food, it is released during normal protein digestion and absorbed alongside other amino acids. As a free-form supplement, L-serine is absorbed directly without requiring digestion.

Absorption occurs primarily in the small intestine via active amino acid transport systems. Because L-serine shares transporters with other amino acids (particularly other small neutral amino acids like glycine, alanine, and threonine), taking very large doses alongside protein-rich meals could theoretically create some competition for absorption, though this is unlikely to be clinically significant at typical supplemental doses [1].

One notable feature of L-serine metabolism is that a substantial portion of ingested L-serine may be converted to glycine in the gut before reaching the bloodstream. This gut-level conversion is mediated by serine hydroxymethyltransferase and means that some of the benefits attributed to L-serine supplementation may actually occur through increased glycine availability [1][8].

For clinical protocols using high doses (multiple grams per day), splitting the total dose across several servings improves tolerability and may result in more consistent blood levels than a single large bolus. A Phase I ALS trial demonstrated that oral L-serine at doses up to 15 g twice daily produced approximately a 4-fold rise in cerebrospinal fluid L-serine levels in the highest dose group, confirming that oral supplementation does cross the blood-brain barrier at sufficient concentrations [6].

The Science

L-Serine is transported across intestinal epithelium via sodium-dependent (system ASC, system A) and sodium-independent (system asc, system L) amino acid transport systems. The ASC transporter (ASCT1/SLC1A4 and ASCT2/SLC1A5) is the primary mediator of L-serine uptake in most tissues, including neurons and astrocytes [1][8].

In the CNS, L-serine is synthesized predominantly by astrocytes via the phosphorylated pathway and exported to neurons, which have limited capacity for de novo serine synthesis. This astrocyte-to-neuron serine shuttle is critical for neuronal D-serine production and sphingolipid synthesis. The blood-brain barrier is permeable to L-serine, as demonstrated by the dose-dependent CSF concentration increases observed in Phase I clinical trials [6][8].

A pharmacokinetic consideration relevant to high-dose protocols: oral L-serine supplementation at 400 mg/kg/day in HSAN1 patients produced measurable decreases in plasma 1-deoxysphingolipids within weeks of initiating treatment, with a 59% reduction after one year. This suggests that oral dosing is sufficient to alter systemic sphingolipid metabolism [3][11].

Research & Clinical Evidence

The Basics

L-Serine research spans several distinct areas, from rare genetic conditions to broader neurodegenerative diseases. The quality and stage of evidence varies considerably across these applications.

Hereditary sensory and autonomic neuropathy type 1 (HSAN1) has the strongest clinical evidence. HSAN1 is a rare genetic condition where a mutation causes the sphingolipid-producing enzyme to use the wrong amino acid (alanine instead of serine), generating toxic compounds that progressively damage sensory nerves. A randomized, placebo-controlled trial found that high-dose L-serine (400 mg/kg/day) slowed disease progression and reduced the toxic deoxysphingolipid levels by 59% over one year. This represents Class I evidence for disease modification [3][11].

GRIN-related encephalopathies are another area with encouraging results. These are rare pediatric disorders where mutations in NMDA receptor subunit genes impair brain development. A Phase 2A trial in children found that L-serine treatment for 52 weeks significantly improved motor function and quality of life scores, and normalized EEG patterns in some patients [4][5].

ALS (amyotrophic lateral sclerosis) research is promising but preliminary. A Phase I trial showed that L-serine at doses up to 30 g per day was safe, and exploratory analyses suggested a dose-dependent slowing of functional decline (34% reduction in progression slope). However, this was a small trial (20 patients) with historical controls, and confirmatory Phase II trials are ongoing. The mechanistic rationale centers on L-serine's ability to prevent the misincorporation of the cyanobacterial toxin BMAA into neuroproteins [6][7].

Pain relief has one notable study. A randomized, controlled trial in 168 adults found that a combination of L-serine (594 mg/day) plus EPA (149 mg/day) significantly reduced low-back and knee pain scores compared to placebo after 8 weeks, with effects persisting at 12-week follow-up [13].

Sleep research is limited but positive. One study found that L-serine ingestion improved sleep initiation and maintenance factors compared to placebo. Another found that bedtime L-serine intake helped prevent circadian phase delays [14][15].

Cognitive function and Alzheimer's disease remain in early stages. A Phase IIa trial of L-serine for early-stage Alzheimer's has been initiated (NCT03062449), and a combined metabolic activators study (including L-serine) showed cognitive improvements in AD patients. However, standalone L-serine efficacy for cognitive decline in otherwise healthy adults has not been demonstrated in rigorous trials [7][16].

The Science

HSAN1 (Class I evidence): Fridman et al. (2019) conducted a randomized, double-blind, placebo-controlled trial with open-label extension in symptomatic HSAN1 patients. L-serine 400 mg/kg/day for 1 year produced improvement in CMTNS relative to placebo (-1.5 units, 95% CI -2.8 to -0.1, p=0.03), with evidence of continued improvement in the second year (-0.77, 95% CI -1.67 to 0.13, p=0.09). Deoxysphingamine levels decreased 59% vs. 11% increase in placebo (p<0.001). No serious adverse effects related to L-serine [3].

GRIN-related disorders: A Phase 2A trial (NCT04646447) in children aged 2-18 with GRIN loss-of-function variants treated with L-serine for 52 weeks demonstrated significant improvement in Gross Motor Function-88 total score (p=0.002) and Pediatric Quality of Life total score (p=0.00068). Vineland Adaptive Behavior Composite showed a mean increase of 21.6 points. EEG normalization occurred in 5/N children. One discontinuation due to irritability and insomnia [4].

ALS: Levine et al. (2017) Phase I trial: 20 ALS patients, oral L-serine 0.5-15 g twice daily for 6 months. Two withdrawals for GI side effects (bloating, nausea). Three deaths during trial (within expected range for ALS). Exploratory analysis: ALSFRS-R slope showed 34% reduction in progression rate (p=0.044, linear mixed effects model corrected for initial FVC and symptom duration). CSF L-serine increased approximately 4-fold in highest dose group [6].

Primate neurotoxin model: Davis et al. (2020) demonstrated that vervets co-administered L-serine with BMAA (cyanobacterial neurotoxin) for 140 days showed significantly reduced TDP-43 inclusions, protein aggregates, and pro-inflammatory microglia in spinal cord compared to BMAA-only controls [7].

Chronic pain: Sasahara et al. (2020) RCT (n=168): L-serine 594 mg + EPA 149 mg daily for 8 weeks. JLEQ scores (low-back pain) significantly better in active group (14.2 vs 19.0). BPI scores 11-27% improved for worst pain, average pain, and movement pain at weeks 4 and 8 (p<=0.028 and p<=0.019). No adverse events [13].

Diabetes and metabolic health: Preclinical evidence suggests L-serine supplementation attenuates alcoholic fatty liver by enhancing homocysteine metabolism and may lower diabetes incidence by improving blood glucose homeostasis, though human RCTs are limited in this area [7][17].

Evidence & Effectiveness Matrix

Category

Longevity & Neuroprotection

Evidence Strength
7/10
Reported Effectiveness
6/10
Summary
Strong mechanistic rationale and Class I HSAN1 evidence. Promising ALS/neurodegeneration data. Community interest high but experiential data sparse.

Category

Focus & Mental Clarity

Evidence Strength
3/10
Reported Effectiveness
5/10
Summary
Mechanistically plausible via phosphatidylserine/sphingolipid pathways. Limited clinical trials for standalone cognitive effects. Community reports mixed.

Category

Memory & Cognition

Evidence Strength
3/10
Reported Effectiveness
4/10
Summary
Alzheimer's trial initiated; combined metabolic activator data encouraging. No standalone RCTs in healthy adults. Community largely redirects to other nootropics.

Category

Sleep Quality

Evidence Strength
3/10
Reported Effectiveness
5/10
Summary
Two small positive studies on sleep initiation/maintenance and circadian phase. Community reports of improved dream vividness. Limited evidence base.

Category

Mood & Wellbeing

Evidence Strength
2/10
Reported Effectiveness
4/10
Summary
Animal studies show anxiolytic effects. One dramatic positive anecdote in community. No human RCTs for mood in healthy adults.

Category

Pain Management

Evidence Strength
4/10
Reported Effectiveness
4/10
Summary
One RCT showing benefit for low-back/knee pain (combined with EPA). No standalone L-serine pain trials. No community reports.

Category

Skin Health

Evidence Strength
2/10
Reported Effectiveness
3/10
Summary
L-serine supports keratin synthesis and ceramide production mechanistically. One anecdotal community report. No clinical trials.

Category

Side Effect Burden

Evidence Strength
7/10
Reported Effectiveness
3/10
Summary
Consistent evidence of favorable safety profile across clinical trials. GI upset at high doses is the primary concern. Very low side effect reports in community. Score reflects low burden.

Benefits & Potential Effects

The Basics

L-Serine's benefits are primarily structural and metabolic rather than immediately noticeable. Unlike stimulant-type supplements that produce rapid subjective effects, L-serine supports underlying biological infrastructure. Benefits are most apparent in specific clinical populations and may be subtle or incremental in healthy individuals.

Neuroprotection and nerve health represent L-serine's strongest applications. In HSAN1, high-dose L-serine directly addresses the disease mechanism by outcompeting alanine at the serine palmitoyltransferase enzyme, reducing the production of neurotoxic deoxysphingolipids. This is one of the clearest examples of a supplement with a well-understood, disease-modifying mechanism [3][11].

Brain development support has been demonstrated in GRIN-related disorders, where L-serine supplementation improved motor function, adaptive behavior, and quality of life in children with NMDA receptor subunit mutations [4][5].

Sleep support is an emerging area. Early studies suggest L-serine may improve sleep initiation and maintenance and help prevent circadian phase delays when taken before bedtime [14][15].

Pain relief showed promise in one trial combining L-serine with EPA for chronic low-back and knee pain. The proposed mechanism involves L-serine supporting damaged nerve cells while EPA reduces inflammation [13].

One-carbon metabolism support is a systemic benefit. By feeding the folate cycle, L-serine contributes to DNA synthesis, methylation, and amino acid interconversion. This may be particularly relevant during periods of rapid cell division (immune activation, wound healing, exercise recovery) [1][8].

Metabolic health is an emerging research area. Preclinical evidence suggests L-serine may support liver health and glucose homeostasis, though human trials are limited [17].

The Science

Sphingolipid normalization (HSAN1): Garofalo et al. (2011) demonstrated that oral L-serine supplementation reduced production of neurotoxic 1-deoxysphingolipids in both mice and humans with HSAN1. The reduction in deoxysphinganine (deoxySA) and deoxysphingosine (deoxySO) was dose-dependent and correlated with clinical improvement on neuropathy scores [11].

NMDA receptor function support (GRIN disorders): L-serine supplementation at 500 mg/kg/day in GRIN2B-NDD patients increased plasma D-serine availability, restoring function to loss-of-function mutant NMDARs. In vitro electrophysiology confirmed that high-dose D-serine (the endogenous product of L-serine racemization) rescued receptor function in GluN2B mutant-expressing neurons [4][5].

Circadian and sleep effects: Ito et al. (2014) found improved sleep initiation and maintenance factors with L-serine intake. Ohashi et al. (2022) demonstrated that L-serine intake before bedtime prevented circadian phase delay in a real-life setting, suggesting a role in circadian rhythm regulation [14][15].

Homocysteine regulation: Verhoef et al. (2004) showed in a human crossover RCT that dietary serine and cystine attenuated the homocysteine-raising effect of dietary methionine, supporting L-serine's role in methylation homeostasis [12].

When you're taking multiple supplements, it's hard to know which one is doing the heavy lifting. The benefits described above may overlap with effects from other items in your stack, lifestyle changes, or seasonal variation. Doserly helps you untangle that by keeping everything in one place, with timestamps, doses, and outcomes logged together.

Over time, this builds something more valuable than any product review: your personal evidence record. You can see exactly when you started this supplement, what else was in your routine at the time, and how your tracked health markers responded. That clarity makes the difference between guessing and knowing, whether you're talking to a healthcare provider or simply deciding if it's worth reordering.

Symptom trends

Capture changes while they are still fresh.

Log symptoms, energy, sleep, mood, and other observations alongside protocol events so patterns do not live only in memory.

Daily notesTrend markersContext history

Trend view

Symptom timeline

Energy
Tracked
Sleep note
Logged
Pattern
Visible

Symptom tracking is informational and should be interpreted with a qualified clinician.

Side Effects & Safety

The Basics

L-Serine has a favorable safety profile at typical supplemental doses. Most people tolerate 500 mg to 3 g per day without any issues. The safety data from clinical trials, where doses up to 25-30 g per day have been used for up to one year, provides substantial reassurance about the compound's tolerability [2][6].

The most common side effect at higher doses is gastrointestinal discomfort, including nausea, bloating, gas, and occasionally loose stools. These effects are dose-dependent and tend to occur primarily with large single doses taken on an empty stomach. Splitting doses across meals and increasing gradually typically resolves these issues [2][6].

At very high doses (above approximately 25 g per day), more significant effects have been reported, including nausea, vomiting, and in rare cases, nystagmus (involuntary eye movements) and seizures. These effects are reversible upon dose reduction [2].

In the ALS Phase I trial, two patients withdrew due to GI problems: one experienced bloating at 15 g twice daily after 4 months, and another had nausea and vomiting. These were the only treatment-related withdrawals [6]. In pediatric GRIN trials, one patient discontinued due to irritability and insomnia [4].

There are no known significant drug interactions documented for L-serine. However, individuals taking medications that affect excitatory/inhibitory neurotransmitter balance (such as anticonvulsants or agents affecting NMDA receptor function) should discuss L-serine supplementation with their healthcare provider, as L-serine indirectly influences NMDA receptor activity through D-serine production [2][8].

Special populations:

  • Pregnancy and breastfeeding: Insufficient safety data for supplemental doses. Stick to dietary amounts.
  • Kidney disease: Exercise caution with amino acid supplements that add nitrogen load. Medical supervision recommended.
  • Liver disease: L-serine metabolism involves hepatic pathways. Consult a healthcare provider before supplementing.
  • Inborn errors of serine metabolism: Require specialist care; do not self-supplement.

The Science

Safety data from clinical trials:

Study

Levine et al. (2017)

Population
ALS patients (n=20)
Dose
1-30 g/day
Duration
6 months
Safety Finding
Generally well tolerated. 2 GI-related withdrawals. 3 deaths (expected for ALS).

Study

Fridman et al. (2019)

Population
HSAN1 patients
Dose
400 mg/kg/day (~25 g)
Duration
2 years
Safety Finding
No serious adverse effects related to L-serine.

Study

Phase 2A GRIN trial (2024)

Population
Children (n=variable)
Dose
Clinical doses, 52 weeks
Duration
1 year
Safety Finding
1 discontinuation (irritability/insomnia). Generally well tolerated.

Study

Miura et al. (2021)

Population
Healthy adults
Dose
Up to 12 g/day
Duration
4 weeks
Safety Finding
No side effects reported at this dosage.

Study

Sasahara et al. (2020)

Population
Adults with pain (n=168)
Dose
594 mg/day
Duration
8 weeks
Safety Finding
No adverse events observed.

Theoretical concerns:

  • Serine has been identified as a limiting factor for cancer cell growth in some research contexts. However, this relates to intracellular serine availability in tumor metabolism, not oral supplementation in healthy individuals [18].
  • D-serine (not L-serine) at high doses can cause nephrotoxicity in animal models. L-serine supplementation increases D-serine levels only modestly through racemase conversion and does not appear to share this concern [2][9].

Managing side effect risks across a multi-supplement stack can feel overwhelming, especially when interactions between supplements, medications, and foods add layers of complexity. Doserly brings all of that into a single safety view so nothing falls through the cracks.

Rather than researching every possible interaction yourself, the app checks your full stack automatically and flags supplement-drug and supplement-supplement interactions that warrant attention. If you do experience something unexpected, logging it takes seconds, and over time the app helps you spot patterns: whether symptoms correlate with specific doses, timing, or combinations. One place for the safety picture that matters most when your stack grows beyond a few bottles.

Labs and context

Connect protocol changes to labs and health markers.

Doserly can keep lab results, biomarkers, symptoms, and dose history close together so follow-up conversations have better context.

Lab valuesBiomarker notesTrend context

Insights

Labs and trends

Lab marker
Imported
Dose change
Matched
Trend note
Saved

Doserly organizes data; it does not diagnose or interpret labs for you.

Dosing & Usage Protocols

The Basics

L-Serine dosing spans a wide range depending on the goal. For general wellness supplementation, most people use 500 to 3,000 mg per day. Clinical research protocols use dramatically higher doses, sometimes exceeding 25 g per day, but these require medical supervision.

General wellness and cognitive support: 500-3,000 mg/day, taken once daily or divided into two doses. This range is intended to supplement dietary intake and support one-carbon metabolism and membrane lipid production [2].

Training and recovery support: 1-3 g/day during heavy training blocks, paired with adequate total protein intake (1.2-1.6 g/kg/day). L-serine supports membrane turnover and methylation demands that increase with intense physical activity [2].

Older adults and wound care: 1-2 g/day, layered on top of sufficient total protein (at least 1.0-1.2 g/kg/day). L-serine may help support cell proliferation and tissue repair demands [2].

Neurological protocols (clinician-directed only):

  • HSAN1: 400 mg/kg/day (approximately 25 g/day for a 63 kg person), divided into multiple daily doses with laboratory monitoring [3].
  • ALS (exploratory): Up to 15 g twice daily (30 g total), as tested in Phase I trials. Requires enrollment in a clinical protocol or close medical supervision [6].
  • GRIN-related disorders: 500 mg/kg/day in 4 divided doses for 12 months (pediatric, clinician-directed) [5].

Starting guidance for new users: Begin with 500 mg per day for 1-2 weeks, then increase gradually if tolerated and if a higher dose is warranted for your goals. Most GI issues can be avoided by starting low and dividing doses.

The Science

Pharmacokinetic considerations:

A pharmacokinetic modeling study (Miura et al., 2021) evaluated graded oral L-serine supplementation in healthy adults and confirmed that doses up to 12 g/day for 4 weeks produced no adverse effects and resulted in dose-proportional increases in plasma serine concentrations [19].

In the ALS Phase I trial, CSF L-serine concentrations showed an approximately 4-fold increase in the highest dose group (15 g twice daily), confirming blood-brain barrier penetration at pharmacologically relevant concentrations. The dose-response relationship for ALSFRS-R slope reduction was linear across the tested range (0.5-15 g twice daily) [6].

Application

General wellness

Typical Dose
500-3,000 mg/day
Frequency
Once or twice daily
Duration
Ongoing
Evidence Level
Extrapolated from safety data

Application

Training/recovery

Typical Dose
1-3 g/day
Frequency
Twice daily
Duration
Training blocks
Evidence Level
Expert opinion

Application

HSAN1

Typical Dose
400 mg/kg/day
Frequency
Multiple daily doses
Duration
Ongoing
Evidence Level
Class I (RCT)

Application

ALS (exploratory)

Typical Dose
Up to 30 g/day
Frequency
Twice daily
Duration
6+ months
Evidence Level
Phase I

Application

GRIN disorders

Typical Dose
500 mg/kg/day
Frequency
4 daily doses
Duration
12+ months
Evidence Level
Phase 2A

Application

Chronic pain

Typical Dose
594 mg/day + EPA
Frequency
Once daily
Duration
8+ weeks
Evidence Level
Single RCT

When your stack includes several supplements, each with its own dose, form, and timing requirements, the logistics alone can derail consistency. Doserly consolidates all of it into one protocol view, so every dose across your entire routine is accounted for without spreadsheets or guesswork.

The app also tracks cumulative intake for nutrients that appear in multiple products. If your multivitamin, standalone supplement, and fortified protein shake all contain the same nutrient, Doserly adds them up and shows you the total alongside recommended and upper limits. Managing a thoughtful supplement protocol shouldn't require a degree in nutrition science. The app handles the complexity so you can focus on staying consistent.

Log first, look for patterns

Turn symptom and safety notes into a clearer timeline.

Doserly helps you log doses, symptoms, and safety observations side by side so patterns are easier to discuss with a qualified clinician.

Dose historySymptom timelineSafety notes

Pattern view

Logs and observations

Dose entry
Time-stamped
Symptom note
Logged
Safety flag
Visible

Pattern visibility is informational and should be reviewed with a clinician.

What to Expect (Timeline)

Days 1-7: Most users notice no immediate subjective effects. L-serine does not produce stimulant-like or sedative effects at typical supplemental doses. Some individuals report subtle improvements in sleep quality when taking L-serine before bedtime. GI adjustment (mild bloating or loose stools) may occur if starting at higher doses.

Weeks 2-4: If benefits occur at wellness doses, they tend to be subtle and accumulate gradually. Users interested in cognitive support may notice improvements in mental stamina or sleep quality, though these effects are often difficult to distinguish from other lifestyle factors. Tissue levels of serine-derived lipids (sphingolipids, phosphatidylserine) are building during this period.

Weeks 4-8: This is a reasonable evaluation window for wellness supplementation. If no benefit is perceived after 8 weeks at an appropriate dose with a sufficient diet, discontinuation is reasonable.

Months 2-6: Clinical applications (HSAN1, GRIN disorders) require months of consistent use before measurable outcomes. The HSAN1 RCT measured outcomes at 12 months. Deoxysphingolipid reductions were measurable within weeks but clinical improvement on neuropathy scores emerged over months.

Important note: L-serine benefits are structural and metabolic. Unlike nootropics with immediate subjective effects, L-serine works by maintaining the biochemical infrastructure that supports brain and nerve function. Expect incremental, cumulative benefits rather than dramatic acute changes.

Interactions & Compatibility

Synergistic

  • Vitamin B9 (Folic Acid, Methylfolate): Critical cofactor for one-carbon metabolism. Folate accepts the one-carbon unit donated by L-serine during the SHMT reaction. Adequate folate status maximizes the utility of supplemental L-serine for methylation and nucleotide synthesis.
  • Vitamin B12: Required for the methionine synthase reaction that recycles homocysteine to methionine. Works in concert with L-serine-derived one-carbon units to maintain methylation capacity.
  • Vitamin B6: Cofactor for serine hydroxymethyltransferase and multiple transamination reactions. Supports both L-serine utilization and the broader aminotransferase network.
  • Choline: Both choline and L-serine contribute to phospholipid synthesis and one-carbon metabolism through complementary pathways. Co-supplementation supports membrane integrity and methylation.
  • Glycine: L-serine converts to glycine via SHMT. Glycine and serine are metabolically interconvertible and both support collagen synthesis, inhibitory neurotransmission, and one-carbon metabolism.
  • EPA/DHA (Fish Oil): The combination of L-serine with EPA showed synergistic pain relief in an RCT. L-serine supports nerve cell structure while omega-3 fatty acids reduce neuroinflammation [13].
  • Zinc: Supports methylation enzymes and is involved in serine metabolism pathways. Adequate zinc status supports optimal one-carbon metabolism.
  • Phosphatidylserine: While phosphatidylserine is a downstream product of L-serine, co-supplementation may support different aspects of neuronal membrane health. L-serine provides precursor support while phosphatidylserine delivers the finished lipid directly.

Caution / Avoid

  • D-Serine: Do not combine L-serine and D-serine supplementation without clinical guidance. Both influence NMDA receptor activity through different mechanisms, and combined use could produce excessive NMDA activation.
  • Anticonvulsants: L-serine indirectly influences excitatory neurotransmission via D-serine production. Individuals taking anticonvulsants should consult their prescriber before adding L-serine, particularly at higher doses.
  • Levodopa: If using protein-timing strategies for Parkinson's disease management, review all amino acid supplements with your neurologist. L-serine may compete with levodopa for amino acid transport across the blood-brain barrier.
  • Folate antagonists (e.g., methotrexate): L-serine feeds the folate cycle. Medications that inhibit folate metabolism may interact with L-serine's metabolic effects. Coordinate with prescribing physician.

How to Take / Administration Guide

Recommended form: L-Serine free-form powder or capsules. Most commercial products provide 500 mg per capsule. Powder form allows more flexible dosing.

Timing considerations:

  • For sleep support, take L-serine 30-60 minutes before bedtime [14][15].
  • For general wellness, timing is flexible; take with meals you rarely skip for consistency.
  • For GI comfort, divide higher doses (e.g., morning and evening with meals).

Food pairing: L-serine can be taken with or without food. Taking with meals may improve tolerance at higher doses and reduce the chance of GI upset. No specific food requirements for absorption.

Powder mixing: L-serine powder dissolves well in water and has a mildly sweet taste. It can be mixed into smoothies, juice, or water. It is heat-stable and can be added to warm beverages.

Cycling: There is no strong evidence that L-serine requires cycling. For wellness supplementation, continuous daily use is standard. For clinical applications, continuous use is the norm in published trials (up to 2 years in the HSAN1 trial).

Starting protocol:

  1. Begin with 500 mg per day for 1-2 weeks
  2. If tolerated, increase to 1-2 g per day if your goal warrants it
  3. Evaluate at 4-8 weeks
  4. If no perceived benefit and diet is adequate in protein, discontinuation is reasonable

Choosing a Quality Product

Third-party certifications to look for:

  • USP Verified Mark (identity, strength, purity testing)
  • NSF Certified for Sport (screens for banned substances; relevant for athletes)
  • Informed Sport certification (batch testing for WADA-banned substances)
  • GMP (Good Manufacturing Practices) certification

Form quality indicators:

  • Products should clearly specify "L-Serine" on the label (not generic "serine" and not "D-serine")
  • Certificate of Analysis (CoA) should be available, confirming identity, potency, and absence of contaminants (heavy metals, microbial)
  • Powder should dissolve cleanly in water and be nearly neutral or mildly sweet in taste

Red flags:

  • Products listing only "serine" without specifying L- or D- form
  • Proprietary blends that do not disclose the amount of L-serine per serving
  • Products combining L-serine with stimulants or other active compounds at undisclosed doses
  • D-serine being marketed as a substitute for L-serine (they are not interchangeable)

Confusion with phosphatidylserine: Many consumers confuse L-serine with phosphatidylserine (PS). These are different compounds. L-serine is a free amino acid; phosphatidylserine is a phospholipid. They have different dosing, mechanisms, and evidence bases. If your goal is specifically cognitive support with direct phospholipid supplementation, phosphatidylserine may be more appropriate. If your goal is to support the upstream metabolic pathways (sphingolipid synthesis, one-carbon metabolism, neuroprotection), L-serine is the relevant supplement.

Storage & Handling

L-Serine supplements should be stored at room temperature (15-25 C / 59-77 F) in a dry place away from direct sunlight and moisture. Both capsule and powder forms are stable under normal storage conditions.

Powder form should be kept in a tightly sealed container to prevent moisture absorption and clumping. L-serine is water-soluble and can absorb ambient humidity in unsealed containers.

L-serine is chemically stable and not particularly sensitive to heat or light degradation. When properly stored, supplements should maintain potency through the manufacturer's expiration date.

Lifestyle & Supporting Factors

Dietary sources: L-Serine is found in most protein-containing foods. Rich sources include eggs, meat, fish, dairy, soy products, legumes, nuts, and seeds. A varied omnivorous diet typically provides 3.5-8 g per day. Plant-based eaters generally meet baseline needs through total protein intake but may have lower overall serine intake depending on protein sources and quantity [1][2].

Protein adequacy: L-serine supplementation is most meaningful when total protein intake is adequate (at least 0.8 g/kg/day for sedentary adults, 1.2-1.6 g/kg/day for active individuals or during recovery). Supplementing L-serine while eating insufficient total protein addresses only one piece of a larger nutritional gap.

B-vitamin and folate status: Because L-serine feeds one-carbon metabolism, its utility is maximized when folate (B9), B12, and B6 are adequate. These nutrients work as a system. Supplementing L-serine alone while deficient in folate would be like adding fuel to an engine with missing spark plugs.

Hydration: Adequate water intake supports amino acid metabolism and renal clearance. This is particularly relevant at higher supplemental doses.

Exercise and recovery: Physical activity increases demand for nucleotide synthesis, methylation, and tissue repair, all pathways that L-serine feeds. Individuals in intensive training blocks or recovering from injury may benefit more from supplementation than sedentary individuals.

Sleep optimization: Given L-serine's emerging sleep-related evidence, pairing supplementation with good sleep hygiene (consistent bedtime, dark/cool environment, limited screens before bed) may amplify any sleep benefits.

Signs that may indicate increased L-serine need: Strict plant-based diets with low total protein, periods of intensive physical training, recovery from injury or surgery, conditions involving neuroinflammation, and genetic conditions affecting serine biosynthesis.

Regulatory Status & Standards

United States (FDA): L-Serine is available as a dietary supplement under DSHEA. It holds Generally Recognized as Safe (GRAS) status. L-serine is FDA-approved for supplemental use, unlike D-serine which is not [2][10].

Canada (Health Canada): L-Serine is available as a Natural Health Product.

European Union (EFSA): L-Serine is permitted in food supplements. No specific health claims have been evaluated by EFSA for L-serine as an individual amino acid.

Australia (TGA): Available as a complementary medicine ingredient.

Athlete & Sports Regulatory Status:

  • WADA: L-Serine is NOT on the WADA Prohibited List and is permitted in-competition and out-of-competition. As a naturally occurring amino acid found in food, it does not trigger anti-doping concerns.
  • USADA, UKAD, Sport Integrity Canada, Sport Integrity Australia: No restrictions on L-serine. Athletes are advised to use third-party tested products (NSF Certified for Sport, Informed Sport) to mitigate contamination risk.
  • GlobalDRO: L-serine can be verified through GlobalDRO (globaldro.com) as a non-prohibited substance.
  • NCAA: No specific restrictions. NCAA recommends athletes use only NSF Certified for Sport or Informed Sport certified supplements.
  • Professional leagues (NFL, NBA, MLB, NHL): No restrictions on naturally occurring amino acids. Individual team policies may apply.

FAQ

What is L-serine used for?
L-Serine is used as a dietary supplement to support one-carbon metabolism, membrane lipid production, and neurological health. Clinical research has studied it for hereditary sensory neuropathy (HSAN1), GRIN-related developmental disorders, and as an exploratory treatment for ALS. In the wellness space, it is used for cognitive support, sleep improvement, and general neuroprotection, though evidence for these everyday uses remains limited.

What is the difference between L-serine and D-serine?
L-serine and D-serine are mirror-image forms of the same amino acid molecule. L-serine is the form used in protein synthesis and is found abundantly in food. D-serine is produced in the brain from L-serine and acts as a co-agonist at NMDA receptors. They have different dosing ranges, mechanisms, safety profiles, and regulatory status. L-serine is FDA-approved for supplemental use; D-serine is not.

What is the difference between L-serine and phosphatidylserine?
L-serine is a free amino acid. Phosphatidylserine is a phospholipid (a fat molecule containing serine) that is a component of cell membranes, particularly in the brain. L-serine is a precursor for phosphatidylserine synthesis. They have distinct evidence bases, dosing protocols, and mechanisms.

How much L-serine should I take per day?
Based on available data, commonly reported ranges for general wellness are 500-3,000 mg per day. Clinical trials have used much higher doses (up to 30 g/day) under medical supervision for specific conditions. Healthcare professionals can provide guidance on appropriate dosing for individual circumstances.

Is L-serine safe?
Based on clinical trial data, L-serine has been used safely at doses up to 25 g/day for up to 1 year and at up to 12 g/day for 4 weeks in healthy adults with no side effects reported. At typical supplemental doses (500-3,000 mg/day), side effects are uncommon. Higher doses may cause GI upset. Always consult a healthcare provider before starting any supplement regimen.

Can L-serine help with ALS?
L-serine is being researched as a potential treatment for ALS. Phase I clinical trials have shown it is safe and tolerable in ALS patients, and exploratory analyses suggested a possible dose-dependent slowing of disease progression. However, these results are preliminary, and L-serine is not approved as an ALS treatment. A healthcare provider can provide current guidance on clinical trial participation.

Does L-serine help with sleep?
Small studies suggest L-serine taken before bedtime may improve sleep initiation and maintenance factors and help prevent circadian phase delays. These findings are promising but based on limited evidence. L-serine is not a sedative and should not be expected to produce dramatic sleep improvements.

Can I get enough L-serine from food?
Most people consuming adequate protein (0.8+ g/kg/day) obtain sufficient L-serine from their diet, as a typical diet provides approximately 3.5-8 g daily. Supplementation may be considered when dietary intake is limited (very low protein diets), during periods of increased demand (intensive training, injury recovery), or for specific clinical applications under medical guidance.

Is L-serine the same as serine?
When supplement labels say "serine" without specifying, they typically mean L-serine. However, it is important to verify that the product specifically states "L-serine" rather than "D-serine" or generic "serine," as the forms have different actions and safety profiles.

Does L-serine cause cancer?
Research has identified serine as a limiting factor for cancer cell growth in certain contexts, meaning some tumor cells depend heavily on serine to proliferate. However, this relates to intracellular serine metabolism within tumors, not to oral supplementation in healthy individuals. There is no evidence that dietary L-serine intake or supplementation at normal doses causes cancer. Individuals with active cancer should discuss all supplements with their oncologist.

Myth vs. Fact

Myth: L-serine and phosphatidylserine are the same thing.
Fact: They are chemically distinct compounds. L-serine is a free amino acid; phosphatidylserine is a phospholipid containing serine as one component. While L-serine is a precursor for phosphatidylserine synthesis, taking L-serine does not produce the same effects as taking phosphatidylserine directly. They have different evidence bases, dosing ranges, and primary applications [1].

Myth: L-serine provides immediate nootropic effects like a brain-boosting stimulant.
Fact: L-serine's benefits are structural and metabolic, operating through membrane lipid synthesis, one-carbon metabolism, and neurotransmitter precursor pathways. These processes unfold over weeks to months. Dramatic single-dose cognitive improvements reported anecdotally are likely attributable to placebo effects, individual variation, or confusion with D-serine (which has more direct NMDA receptor activity) [8][9].

Myth: L-serine supplementation feeds cancer growth.
Fact: While some cancer cells are highly dependent on serine availability for proliferation, this refers to intracellular serine biosynthesis and uptake within tumors. There is no evidence that oral L-serine supplementation at standard doses promotes cancer in healthy individuals. The body tightly regulates serine metabolism, and supplemental intake does not bypass these controls [18].

Myth: L-serine and D-serine are interchangeable.
Fact: L-serine and D-serine have fundamentally different biological roles. L-serine is used for protein synthesis, sphingolipid production, and one-carbon metabolism. D-serine is a neuromodulator acting at NMDA receptors. Their dosing ranges differ dramatically (L-serine: 500 mg to 30 g; D-serine: 2-4 g). D-serine has kidney toxicity concerns that L-serine does not share. They should never be substituted for each other without medical guidance [2][9].

Myth: You need to supplement L-serine because the body cannot make enough.
Fact: L-serine is classified as nonessential because healthy individuals synthesize adequate amounts from glucose via the phosphorylated pathway. Supplementation is primarily relevant for individuals with genetic conditions affecting serine metabolism, those with very low protein diets, or during periods of significantly increased demand. Most people eating adequate protein do not need L-serine supplements [1][2].

Myth: High-dose L-serine is a proven treatment for ALS.
Fact: While Phase I trial data show L-serine is safe in ALS patients and exploratory analyses are encouraging, no Phase III RCT has confirmed efficacy. L-serine is investigational for ALS and should only be used in this context under medical supervision, ideally within a clinical trial. Marketing it as a proven ALS treatment would be inaccurate and irresponsible [6][7].

Myth: L-serine from the Okinawa diet is why people in Ogimi live so long.
Fact: While traditional foods in Ogimi, Okinawa contain high L-serine levels, and researchers have proposed a neuroprotective role, longevity in these populations is attributable to multiple interacting factors: caloric moderation, plant-rich diets, physical activity, social connection, and genetics. Attributing longevity to a single amino acid oversimplifies the evidence [7].

Sources & References

Clinical Trials & RCTs

[3] Fridman V, Suriyanarayanan S, Novak P, et al. Randomized trial of L-serine in patients with hereditary sensory and autonomic neuropathy type 1. Neurology. 2019;92(4):e359-e370.

[4] Phase 2A trial: L-serine treatment in patients with GRIN-related encephalopathy. Nat Med. 2024.

[5] den Hollander B, et al. Evidence for effect of L-serine, a novel therapy for GRIN2B-related neurodevelopmental disorder. J Inherit Metab Dis. 2023;46(1):123-132.

[6] Levine TD, Miller RG, Bradley WG, et al. Phase I clinical trial of safety of L-serine for ALS patients. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(1-2):107-111.

[11] Garofalo K, Penno A, Schmidt BP, et al. Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1. J Clin Invest. 2011;121(12):4735-45.

[12] Verhoef P, Steenge GR, Boelsma E, et al. Dietary serine and cystine attenuate the homocysteine-raising effect of dietary methionine: a randomized crossover trial in humans. Am J Clin Nutr. 2004;80(3):674-9.

[13] Sasahara I, Yamamoto A, Takeshita M, et al. L-Serine and EPA Relieve Chronic Low-Back and Knee Pain in Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. J Nutr. 2020;150(9):2278-2286.

[14] Ito Y, Takahashi S, Shen M, Yamaguchi K, Satoh M. Effects of L-serine ingestion on human sleep. Springerplus. 2014;3:456.

[15] Ohashi M, Lee SI, Eto T, et al. Intake of L-serine before bedtime prevents the delay of the circadian phase in real life. J Physiol Anthropol. 2022;41(1):31.

[19] Miura N, Matsumoto H, Cynober L, et al. Subchronic tolerance trials of graded oral supplementation with phenylalanine or serine in healthy adults. Nutrients. 2021;13(6):1976.

Reviews & Meta-Analyses

[1] Ye L, Sun Y, Jiang Z, Wang G. L-Serine, an Endogenous Amino Acid, Is a Potential Neuroprotective Agent for Neurological Disease and Injury. Front Mol Neurosci. 2021;14:726665.

[8] Myint SMP, Sun LY. L-serine: Neurological Implications and Therapeutic Potential. Biomedicines. 2023;11(8):2117.

[10] de Koning TJ, Snell K, Duran M, et al. L-serine in disease and development. Biochem J. 2003;371(Pt 3):653-661.

[17] Dietary serine supplementation: Friend or foe? Current Opinion in Clinical Nutrition and Metabolic Care. 2021.

Observational Studies & Preclinical

[7] Bradley WG, Miller RX, Levine TD, et al. Studies of Environmental Risk Factors in Amyotrophic Lateral Sclerosis (ALS) and a Phase I Clinical Trial of L-Serine. Neurotox Res. 2018;33(1):192-198.

[9] Bardaweel SK, Alzweiri M, Ishaqat AA. D-Serine in neurobiology: CNS neurotransmission and neuromodulation. Can J Neurol Sci. 2014;41(2):164-176. Mothet JP, et al. D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. PNAS. 2000;97(9):4926-4931.

[16] Yulug B, Altay O, Li X, et al. Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial. Transl Neurodegener. 2023;12(1):4.

[18] MSKCC Blog: Cancer Stem Cells' Reliance on a Key Amino Acid Could Be an Exploitable Weakness. 2020. (Primary: Baksh et al., Nature Cell Biology 2020)

Government & Institutional Sources

[2] WebMD. Serine: Uses, Side Effects, and More. Therapeutic Research Center, LLC. Accessed 2026.

Same Category (Amino Acids)

Common Stacks / Pairings

L-Serine for Brain Health & Nerve Function